Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice (Q23917440)

20 October 2023

2

Victor J. Johnson

Victor J

Johnson

1 reference

20 October 2023

3

Dori R. Germolec

Dori R

Germolec

1 reference

20 October 2023

M. Renee Prater

1

M Renee

Prater

1 reference

16143434

20 October 2023

Steven D. Holladay

series ordinal

5

author given names

Steven D

author last names

Holladay

1 reference

16143434

on focus list of Wikimedia project

20 October 2023

language of work or name

English

0 references

publication date

16 January 2006

0 references

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

0 references

volume

24

0 references

issue

3

0 references

page(s)

263-271

0 references

Wikimedia–NIOSH collaboration

0 references

cites work

Innate immune recognition and control of adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Immunotherapeutic uses of CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

CpG oligodeoxynucleotide enhances tumor response to radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Ex vivo human placenta models: transport of immunoglobulin G and its subclasses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Bacterial DNA in house and farm barn dust

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Airborne endotoxin predicts symptoms in non-mouse-sensitized technicians and research scientists exposed to laboratory mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Endotoxins and IgG antibodies as indicators of occupational exposure to the microbial contaminants of metal-working fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

On the fate of orally ingested foreign DNA in mice: chromosomal association and placental transmission to the fetus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Gene transfer and expression in progeny after intravenous DNA injection into pregnant mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Transplacental genetic immunization after intravenous delivery of plasmid DNA to pregnant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Genetic control of ocular morphogenesis: defective lens development associated with ocular anomalies in C57BL/6 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Maternal immune stimulation reduces both placental morphologic damage and down-regulated placental growth-factor and cell cycle gene expression caused by urethane: are these events related to reduced teratogenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Tetanus toxoid and congenital abnormalities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Phosphorothioate backbone modification modulates macrophage activation by CpG DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Reproductive toxicology studies and immunotherapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Pregnancy and the immune system: between tolerance and rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Synergistic teratogenic effect produced in mice by whole cell pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Exposure to yellow fever vaccine in early pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Heme oxygenase is downregulated in stress-triggered and interleukin-12-mediated murine abortion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Soluble receptors neutralizing TNF-alpha and IL-1 block stress-triggered murine abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

Identification of the causes of intrauterine death during 310 consecutive autopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.105

10.1016/J.VACCINE.2005.07.105

7 January 2021

Identifiers

DOI

0 references

Fatcat ID

release_jb3wdxxuabgo3k2eovczixh5q4

0 references

NIOSHTIC-2 ID

20028999

0 references